Progress in research on pneumococcal surface adhesin A and surface membrane protein A

Chinese Journal of Biologicals

Volumn 24, Issue 11, 2011, Pages 1368-1372

  Tang, Yu Long ^a   Li, Qi Ming ^a  

^a NATIONAL VACCINE AND SERUM INSTITUTE   (China)

Author keywords

Streptococcus, pneumoniae; Surface adhesion A; Surface membrane protein A

Indexed keywords

MEMBRANE ANTIGEN; MEMBRANE PROTEIN; PROTEIN ADHESIN A; SURFACE MEMBRANE PROTEIN A; UNCLASSIFIED DRUG;

BACTERIUM ISOLATE; GENETIC ANALYSIS; NONHUMAN; PROTEIN FUNCTION; PROTEIN STRUCTURE; REVIEW; STREPTOCOCCUS PNEUMONIAE;

STREPTOCOCCUS PNEUMONIAE;

EID: 84855425194     PISSN: 10045503     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (33)

1. Lynch, JP 3rd, Zhanel GG. 2010. Streptococcus pneumoniae: epidemiology and risk factors, evolution of antimicrobial resistance, and impact of vaccines [J]. Curr Opin Pulm Med, 2010, 16 (3): 217-225.
2. Romero-Steiner S, Pilishvili T, Sampson JS, et al. Inhibition of pneumococcal adherence to human nasopharyngeal epithelial cells by anti-PsaA antibodies [J]. Clin Diag Lab Immunol, 2003, 10 (2): 246-251. (Pubitemid 36314448)
3. Anderton JM, Rajam G, Romero-Steiner S, et al. E-cadherin is a receptor for the common protein pneumococcal surface adhesin A (PsaA) of Streptococcus pneumoniae [J]. Microb Pathog, 2007, 42 (5-6): 225-236. (Pubitemid 46661895)
4. Crook J, Tharpe JA, Johnson SE, et al. Immunoreactivity of five monoclonal antibodies against the 37-kilodalton common cell wall protein (PsaA) of Streptococcus pneumoniae [J]. Clin Diagn Lab Immunol, 1998, 5 (2): 205-210. (Pubitemid 28161190)
5. Palaniappan R, Singh S, Singh UP, et al. Differential PsaA-, PspA-, PspC-, and PdB-specific immune responses in a mouse model of pneumococcal carriage [J]. Infect Immun, 2005, 73 (2): 1006-1013. (Pubitemid 40165761)
6. Scott JA, Obiero J, Hall AJ, et al. Validation of immunoglobulin G enzyme-linked immunosorbent assay for antibodies to pneumococcal surface adhesin A in the diagnosis of pneumococcal pneumonia among adults in Kenya [J]. J Infect Dis, 2002, 186 (2): 220-226. (Pubitemid 34765510)
7. Scott JA, Marston EL, Hall AJ, et al. Diagnosis of pneumococcal pneumonia by psaA PCR analysis of lung aspirates from adult patients in Kenya [J]. J Clin Microbiol, 2003, 41 (6): 2554-2559. (Pubitemid 36712467)
8. Scott JA, Mlacha Z, Nyiro J, et al. Diagnosis of invasive pneumococcal disease among children in Kenya with enzyme-linked immunosorbent assay for immunoglobulin G antibodies to pneumococcal surface adhesin A [J]. Clin Diagn Lab Immunol, 2005, 12 (10): 1195-1201. (Pubitemid 41475828)
9. Basset A, Thompson CM, Hollingshead SK, et al. Antibody-independent, CD4+T-cell-dependent protection against pneumococcal colonization elicited by intranasal immunization with purified pneumococcal proteins [J]. Infect Immun, 2007, 75 (11): 5460-5464. (Pubitemid 350033635)
10. Lu YJ, Forte S, Thompson CM, et al. Protection against Pneumococcal colonization and fatal pneumonia by atrivalent conjugate of a fusion protein with the cell wall polysaccharide [J]. Infect Immun, 2009, 77 (5): 2076-2083.
11. Pimenta FC, Miyaji EN, Areâs AP, et al. Intranasal immunization with the cholera toxin B subunit-pneumococcal surface antigen A fusion protein induces protection against colonization with Streptococcus pneumoniae and has negligible impact on the nasopharyngeal and oral microbiota of mice [J]. Infect Immun, 2006, 74 (8): 4939-4944. (Pubitemid 44157285)
12. Rajam G, Skinner J, Melnick N, et al. A 28-aa pneumococcal surface adhesin A-derived peptide, P4, augments passive immunotherapy and rescues mice from fatal pneumococcal infection [J]. J Infect Dis, 2009, 199 (8): 1233-1238.
13. Rajam G, Phillips DJ, White E, et al. A functional epitope of the pneumococcal surface adhesin A activates nasopharyngeal cells and increases bacterial internalization [J]. Microb Pathog, 2008, 44 (3): 186-196. (Pubitemid 351163526)
14. Wang S, Li Y, Shi H, et al. Immune responses to recombinant pneumococcal PsaA antigen delivered by live attenuated Salmonella vaccine [J]. Infect Immun, 2010, 78 (7): 3258-3271.
15. Gor DO, Ding X, Li Q, et al. Enhanced immunogenicity of pneumococcal surface adhesin A (PsaA) in mice via fusion to recombinant human B lymphocyte stimulator (BLyS) [J]. Biol Direct, 2011, 6(1): 9-26.
16. Melin MM, Hollingshead SK, Briles DE, et al. Development of antibodies to PspA families 1 and 2 in children after exposure to Streptococcus pneumoniae [J]. Clin Vaccine Immunol, 2008, 15 (10): 1529-1535.
17. Hollingshead SK, Becker R, Briles DE. Diversity of PspA : mosaic genes and evidence for past recombination in Streptococcus pneumoniae [J]. Infect Immun, 2000, 68 (10): 5889-5900.
18. Hollingshead SK, Baril L, Ferro S, et al. Pneumococcal surface protein A (PspA) family distribution among clinical isolates from adults over 50 years of age collected in seven countries [J]. J Med Microbiol, 2006, 55 (Pt2): 215-221. (Pubitemid 43201750)
19. Xin W, Li Y, Mo H, et al. PspA family fusion proteins delivered by attenuated Salmonella enterica serovar Typhimurium extend and enhance protection against Streptococcus pneumoniae [J]. Infect Immun, 2009, 77 (10): 4518-4528.
20. Jarva H, Jokiranta TS, Würzner R, et al. Complement resistance mechanisms of streptococci [J]. Mol Immunol, 2003, 40 (2-4): 95-107. (Pubitemid 36959820)
21. Ochs MM, Bartlett W, Briles DE, et al. Vaccine-induced human antibodies to PspA augment complement C3 deposition on Streptococcus pneumoniae [J]. Microb Pathog, 2008, 44 (3): 204-214. (Pubitemid 351163528)
22. Abeyta M, Hardy GG, Yother J. Genetic alteration of capsule type but not PspA type affects accessibility of surface-bound complement and surface antigens of Streptococcus pneumoniae [J]. Infect Immun, 2003, 71 (1): 218-225. (Pubitemid 36026023)
23. Shaper M, Hollingshead SK, Benjamin WH Jr, et al. PspA protects Streptococcus pneumoniae from killing by apolactoferrin, and antibody to PspA enhances killing of pneumococci by apolactoferrin [J]. Infect Immun, 2004, 72 (9): 5031-5040. (Pubitemid 39223387)
24. Daniels CC, Coan P, King J, et al. The proline-rich region of pneumococcal surface proteins A and C contains surface-accessible epitopes common to all pneumococci and elicits antibody-mediated protection against sepsis [J]. Infect Immun, 2010, 78 (5): 2163-2172.
25. Briles DE, Hollingshead SK, King J, et al. Immunization of humans with recombinant pneumococcal surface protein A (rPspA) elicits antibodies that passively protect mice from fatal infection with Streptococcus pneumoniae bearing heterologous PspA [J]. J Infect Dis, 2000, 182 (6): 1694-1701.
26. Csordas FC, Perciani CT, Darrieux M, et al. Protection induced by pneumococcal surface protein A(PspA) is enhanced by conjugation to a Streptococcus pneumoniae capsular polysaccharide [J]. Vaccine, 2008, 26 (23): 2925-2929.
27. Moreno AT, Oliveira MLS, Ferreira DM, et al. Immunization of mice with single PspA fragments induces antibodies capable of mediating complement deposition on different pneumococcal strains and cross-protection [J]. Clin Vaccine Immunol, 2010, 17 (3): 439-446.
28. Darrieux M, Miyaji EN, Ferreira DM, et al. Fusion proteins containing family 1 and family 2 PspA fragments elicit protection against Streptococcus pneumoniae that correlates with antibody-mediated enhancement of complement deposition [J]. Infect Immun, 2007, 75 (12): 5930-5938. (Pubitemid 350207833)
29. Miyaji EN, Ferreira DM, Lopes AP, et al. Analysis of serum cross-reactivity and cross-protection elicited by immunization with DNA vaccines against Streptococcus pneumoniae expressing PspA fragments from different clades [J]. Infect Immun, 2002, 70 (9): 5086-5090.
30. Briles DE, Ades E, Paton JC, et al. Intranasal immunization of mice with a mixture of the pneumococcal proteins PsaA and PspA is highly protective against nasopharyngeal carriage of Streptococcus pneumoniae [J]. Infect Immun, 2000, 68 (2): 796-800. (Pubitemid 30056538)
31. Xin W, Wanda SY, Li Y, et al. Analysis of type II secretion of recombinant pneumococcal PspA and PspC in a Salmonella enterica serovar Typhimurium vaccine with regulated delayed antigen synthesis [J]. Infect Immun, 2008, 76(7): 3241-3254.
32. Ferreira DM, Miyaji EN, Oliveira ML, et al. DNA vaccines expressing pneumococcal pneumococcal surface protein A (PspA) elicit protection levels comparable to recombinant protein [J]. J Med Microbiol, 2006, 55 (Pt4): 375-378.
33. Oliveira MLS, Miyaji EN, Ferreira DM, et al. Combination of pneumococcal surface protein A (PspA) with whole cell pertussis vaccine increases protection against pneumococcal challenge in mice [J]. PLoS One, 2010, 5 (5): e10863.